Doxorubicin Withdrawn Phase 1 Trials for Rhabdomyosarcoma, Pelvic / Rhabdomyosarcoma, Abdominal / Malignant Neoplasms of Mesothelial and Soft Tissue Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03111069Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children